BridgeMD
New treatment option for Placenta Accreta Spectrum
Official title Placenta Accreta Spectrum Outcome After Uterine Conservation
ClinicalTrials.gov ID: NCT04866888
What this study is testing
- What it's testing
- study will be carried out on patients with placenta accreta spectrum having done uterine conservation and recording immediate outcome of conservation regarding success of the procedure, amount of blood loss and amount of blood transfused and followed up to check the return of menses, any uterine abnormalities by ultrasound or hysteroscopy especially isthmocele and intrauterine synechia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 40, women only
You may be able to join if
- Diagnosed sonographically to have placenta accreta spectrum.
- Pregnancy is singleton and fetus is alive.
- Elective caesarean section done from 35 gestational weeks.
You likely can't join if
- Patients requesting hysterectomy.
- Coexisting uterine pathology such as fibroids or gynaecological malignancies.
- Patients with bleeding diathesis.
- Morbid obesity of BMI \>40.
- Patients having labour pains or vaginal bleeding before scheduled intervention.
The study team makes the final eligibility decision.
Where it's taking place
- Alexandria, Alexandria Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alexandria, Alexandria Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.